Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Patrick Derigs"'
Autor:
Patrick Derigs, Carsten Müller-Tidow
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 1, Pp 101210- (2024)
Externí odkaz:
https://doaj.org/article/ef38f26a433f4da1b1f9e2226af6bd77
Autor:
Maria-Luisa Schubert, Anita Schmitt, Angela Hückelhoven-Krauss, Brigitte Neuber, Alexander Kunz, Philip Waldhoff, Dominik Vonficht, Schayan Yousefian, Lea Jopp-Saile, Lei Wang, Felix Korell, Anna Keib, Birgit Michels, Dominik Haas, Tim Sauer, Patrick Derigs, Andreas Kulozik, Joachim Kunz, Petra Pavel, Sascha Laier, Patrick Wuchter, Johann Schmier, Gesine Bug, Fabian Lang, Nicola Gökbuget, Jochen Casper, Martin Görner, Jürgen Finke, Andreas Neubauer, Mark Ringhoffer, Denise Wolleschak, Monika Brüggemann, Simon Haas, Anthony D. Ho, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-17 (2023)
Abstract Background Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs) might improve clinical outcome of patients with B cell malignancies. This is the first report on a third-generation CART dose-escalating, phase-1/2 invest
Externí odkaz:
https://doaj.org/article/26e8df351a78481d84b79ca3e21d57c8
Autor:
Patrick Derigs, Thomas Luft, Aleksandar Radujkovic, Paul Schnitzler, Michael Schmitt, Carsten Müller-Tidow, Tilman Schöning, Maria-Luisa Schubert, Ute Hegenbart, Peter Dreger, Stefan Schönland
Publikováno v:
Annals of Hematology
Morbidity and mortality after allogeneic hematopoietic cell transplantation (alloHCT) are still essentially affected by reactivation of cytomegalovirus (CMV). We evaluated 80 seropositive patients transplanted consecutively between March 2018 and Mar
Autor:
Michael Schmitt, Carsten Müller-Tidow, Paul Schnitzler, Felix Korell, Tim Frederik Weber, Patrick Derigs, Tim Sauer, Maria-Luisa Schubert, Peter Dreger, Anita Schmitt
Publikováno v:
Cancers
Volume 13
Issue 7
Cancers, Vol 13, Iss 1684, p 1684 (2021)
Volume 13
Issue 7
Cancers, Vol 13, Iss 1684, p 1684 (2021)
Simple Summary Chimeric antigen receptor T (CAR-T) cells have become clinical practice for the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma. The aim of this retrospective study was to assess infection complications after lymphod
Autor:
Anita Schmitt, Maria-Luisa Schubert, Paul Schnitzler, Peter Dreger, Tim Sauer, Felix Korell, Michael Schmitt, Patrick Derigs, Tim Frederik Weber, Carsten Müller-Tidow
Publikováno v:
Blood. 138:4835-4835
Background: In the past years, chimeric antigen receptor T (CAR-T) cell therapy targeting CD19 have been shown to be a new and effective treatment option in patients with relapsed/refractory non-Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia
Autor:
Michael Schmitt, Patrick Derigs, Thomas Luft, Carsten Müller-Tidow, Maria-Luisa Schubert, Peter Dreger, Paul Schnitzler
Publikováno v:
Blood. 134:5650-5650
Background: Morbidity and mortality after allogeneic hematopoietic cell transplantation (alloHCT) are still essentially affected by reactivation of cytomegalovirus (CMV). Letermovir is the first drug approved for prophylaxis of CMV reactivation in se
Autor:
Barbara Schrörs, Thomas Wölfel, Catherine Wölfel, Anne Bicker, Dirk Schadendorf, Volker Lennerz, Thomas Hankeln, Annette Paschen, Silke Lübcke, Martina Fatho, Patrick Derigs
Publikováno v:
Oncotarget
// Barbara Schrors 1 , Silke Lubcke 1 , Volker Lennerz 1 , Martina Fatho 1 , Anne Bicker 2 , Catherine Wolfel 1 , Patrick Derigs 1 , Thomas Hankeln 2 , Dirk Schadendorf 3 , Annette Paschen 3 , Thomas Wolfel 1 1 Internal Medicine III, University Cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa03b9914ad09ba4edba19614cb98c81
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/45828
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/45828